Tacrolimus ointment neither blocks ultraviolet B nor affects expression of thymine dimers and p53 in human skin
Authors:
- Thilo GambichlerThilo Gambichler
- Axel SchlaffkeASAxel Schlaffke
- Nordwig S. TomiNTNordwig S. Tomi
- Nick OthlinghausNONick Othlinghaus
- Peter AltmeyerPAPeter Altmeyer
- Alexander KreuterAKAlexander Kreuter
- 31 May 2008
- journal article
- clinical trial
- Published by Elsevier in Journal of Dermatological Science
- Vol. 50 (2) , 115-122
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Topical pimecrolimus for skin disease other than atopic dermatitisExpert Opinion on Pharmacotherapy, 2006
- Safety of topical calcineurin inhibitors in atopic dermatitis: Evaluation of the evidenceCurrent Allergy and Asthma Reports, 2006
- Review of the potential photo‐cocarcinogenicity of topical calcineurin inhibitorsJournal of the European Academy of Dermatology and Venereology, 2005
- Ultraviolet radiation and skin cancer: molecular mechanismsJournal of Cutaneous Pathology, 2005
- Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatologyClinical and Experimental Dermatology, 2002
- Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and managementJournal of the American Academy of Dermatology, 2002
- Topical tacrolimus for the treatment of inflammatory skin diseasesExpert Opinion on Pharmacotherapy, 2001
- Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipientsJournal of Laboratory and Clinical Medicine, 2001
- Change in ultraviolet (UV) transmission following the application of vaseline to non-irradiated and UVB-exposed split skinBritish Journal of Dermatology, 2000
- UV Transmission Measurements of Small Skin Specimens with Special Quartz CuvettesDermatology, 2000